
Loading, please wait...

Loading, please wait...

The Indian guidelines on spirometry emphasize that reliable interpretation begins with reliable test performance. The guidance covers patient preparation, equipment requirements, acceptability and repeatability criteria, quality assurance, and interpretation of ventilatory patterns. This matters because a technically poor spirometry test can mimic restriction, obscure obstruction, or create false confidence in a clinical diagnosis. For practicing HCPs, the practical lesson is straightforward: before acting on an abnormal number, check whether the maneuver met quality criteria and whether the results were adequately reproducible. The same principle applies when monitoring change over time—small shifts in FEV1 are meaningful only when test quality is consistent. The document also reinforces that spirometry should be interpreted in clinical context and is not a substitute for a complete evaluation when the question is more complex. This evidence closely matches the conference workshop and PFT symposium emphasis on spirometry technique, quality control, lung volumes, DLCO, and mixed-pattern work-up. For junior clinicians and high-volume respiratory practices, a standardized approach to spirometry can improve diagnostic confidence and reduce avoidable repeat testing.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Indian guidelines on spirometry emphasize that reliable interpretation begins with reliable test performance. The guidance covers patient preparation, equipment requirements, acceptability and repeatability criteria, quality assurance, and interpretation of ventilatory patterns. This matters because a technically poor spirometry test can mimic restriction, obscure obstruction, or create false confidence in a clinical diagnosis. For practicing HCPs, the practical lesson is straightforward: before acting on an abnormal number, check whether the maneuver met quality criteria and whether the results were adequately reproducible. The same principle applies when monitoring change over time—small shifts in FEV1 are meaningful only when test quality is consistent. The document also reinforces that spirometry should be interpreted in clinical context and is not a substitute for a complete evaluation when the question is more complex. This evidence closely matches the conference workshop and PFT symposium emphasis on spirometry technique, quality control, lung volumes, DLCO, and mixed-pattern work-up. For junior clinicians and high-volume respiratory practices, a standardized approach to spirometry can improve diagnostic confidence and reduce avoidable repeat testing.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back